Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
69.06 USD | -0.48% | +2.89% | +12.04% |
Oct. 26 | Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating | MT |
Sep. 26 | Healthequity Insider Sold Shares Worth $143,704, According to a Recent SEC Filing | MT |
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.
Sector
Software
Calendar
2023-12-04
- Q3 2024 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
BUY
Number of Analysts
12
Last Close Price
69.06USD
Average target price
85.83USD
Spread / Average Target
+24.29%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.04% | 5 942 M $ | |
+66.37% | 83 032 M $ | |
+64.02% | 73 552 M $ | |
+28.77% | 61 811 M $ | |
+51.10% | 50 350 M $ | |
+186.60% | 44 107 M $ | |
+53.38% | 35 105 M $ | |
+51.31% | 26 843 M $ | |
+75.36% | 25 499 M $ | |
+44.87% | 25 230 M $ |
- Stock
- Equities
- Stock HealthEquity, Inc. - Nasdaq
- News HealthEquity, Inc.
- HealthEquity Fiscal Q2 Adjusted Profit, Revenue Increase; Boosts Fiscal 2024 Outlook